Vaccines Articles
The National Institutes of Health (NIH) is conducting an early-stage clinical trial to evaluate the safety and efficacy of two licensed seasonal influenza vaccines administered with or without novel adjuvants.
A new study shows the HPV vaccine is far more effective than expected, with benefits extending beyond those who receive the vaccine.
An NIH research team has determined how several antibodies induced by Epstein-Barr virus (EBV) block infection of cells grown in the laboratory.
FDA has given Sanofi SA’s dengue vaccine Dengvaxia a narrow approval since the vaccine can cause severe infections in some people.
The National Meningitis Association has launched a campaign to encourage more teens to get the meningitis booster.
A BYU study found introducing vaccine-hesitant people to people affected by vaccine-preventable diseases can decrease vaccine hesitancy.
Researchers at the University of Oxford in the United Kingdom have linked several genetic variations with the level of protective antibodies generated following routine childhood immunizations.
Sanofi and Merck’s Vaxelis has been approved by the U.S. Food and Drug Administration.
A new study by researchers at Columbia University has found handing a pamphlet about influenza (flu) to parents in pediatricians’ waiting rooms can have a significant impact on increasing the uptake of the flu vaccine.
Valneva USA has received FDA approval of an accelerated dosing regimen for IXIARO (Japanese encephalitis vaccine, inactivated, adsorbed).
A new study conducted by investigators at the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute in Wisconsin has found the flu vaccine does not cause miscarriages in pregnant women.
The WHO advisory board issued its new recommendations on the composition of the influenza vaccines for use in the 2019-20 flu season in the Northern Hemisphere.
